CD44 and hepatocellular carcinoma: Surface biomarkers such as CD44, CD90, epithelial cell adhesion molecule (EpCAM) and CD133 are utilised to identify tumour stem cells in HCC, whose activation profoundly drives the malignant progression of the disease.244, 245, 246